RGEDF (Chemical Works of Gedeon Richter) Days Payable: 0.00 (As of Dec. 2025)


RGEDF Chemical Works of Gedeon Richter PLC RGEDF
94 GF Score
Price $39.59
GF Value $35.22
Valuation Modestly Overvalued
! 3 Warning Signs
View Full Analysis

What is Chemical Works of Gedeon Richter Days Payable?

Chemical Works of Gedeon Richter RGEDF -1.78% 94 Days Payable is 0.00 as of Dec. 2025. GuruFocus rates RGEDF with a GF Score™ of 94/100 and a GF Value™ of $35.22 (Modestly Overvalued). The stock has 3 warning signs investors should review. Among 923 Drug Manufacturers companies, Chemical Works of Gedeon Richter ranks better than 73.02% on this metric.

Chemical Works of Gedeon Richter's average Accounts Payable for the three months ended in Dec. 2025 was $172 Mil. Chemical Works of Gedeon Richter's Cost of Goods Sold for the three months ended in Dec. 2025 was $0 Mil.

The historical rank and industry rank for Chemical Works of Gedeon Richter's Days Payable or its related term are showing as below:

RGEDF' s Days Payable Range Over the Past 10 Years
Min: 62.62   Med: 90.71   Max: 145.18
Current: 145.18

During the past 13 years, Chemical Works of Gedeon Richter's highest Days Payable was 145.18. The lowest was 62.62. And the median was 90.71.

RGEDF's Days Payable is ranked better than
73.02% of 923 companies
in the Drug Manufacturers industry
Industry Median: 90.98 vs RGEDF: 145.18

Chemical Works of Gedeon Richter's Days Payable declined from Jun. 2024 (62.19) to Dec. 2025 (0.00). It may suggest that Chemical Works of Gedeon Richter accelerated paying its suppliers.


Chemical Works of Gedeon Richter Days Payable Related Terms


Chemical Works of Gedeon Richter Days Payable Historical Data

* Premium members only.

The historical data trend for Chemical Works of Gedeon Richter's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chemical Works of Gedeon Richter Days Payable Chart

Chemical Works of Gedeon Richter Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Days Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 94.37 67.04 62.62 84.57 81.08

Chemical Works of Gedeon Richter Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Dec25
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 62.19 0.00 79.02 60.97 0.00

RGEDF vs ZTS, UTHR, VTRS: Days Payable Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Chemical Works of Gedeon Richter's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Chemical Works of Gedeon Richter Days Payable vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Chemical Works of Gedeon Richter's Days Payable distribution charts can be found below:

* The bar in red indicates where Chemical Works of Gedeon Richter's Days Payable falls into.


RGEDF
94GF Score
Chemical Works of Gedeon Richter PLC RGEDF
Days Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Chemical Works of Gedeon Richter Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Chemical Works of Gedeon Richter's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as

Days Payable (A: Dec. 2025 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Dec. 2024 ) + Accounts Payable (A: Dec. 2025 )) / count ) / Cost of Goods Sold (A: Dec. 2025 )*Days in Period
=( (236.689 + 182.058) / 2 ) / 942.591*365
=209.3735 / 942.591*365
=81.08

Chemical Works of Gedeon Richter's Days Payable for the quarter that ended in Dec. 2025 is calculated as:

Days Payable (Q: Dec. 2025 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Jun. 2025 ) + Accounts Payable (Q: Dec. 2025 )) / count ) / Cost of Goods Sold (Q: Dec. 2025 )*Days in Period
=( (162.784 + 182.058) / 2 ) / 0*365 / 4
=172.421 / 0*365 / 4
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Payable →
What does a Days Payable of 0.00 mean?
Chemical Works of Gedeon Richter (RGEDF) has a Days Payable of 0.00 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Chemical Works of Gedeon Richter and its competitors. Over the past decade, Chemical Works of Gedeon Richter's Days Payable has ranged from 62.62 to 145.18. According to the industry distribution chart, Chemical Works of Gedeon Richter ranks #249 out of 923 companies in the Drug Manufacturers industry, placing it in the top 27%.
Is Chemical Works of Gedeon Richter's Days Payable too high?
Chemical Works of Gedeon Richter's current Days Payable is 0.00. Over the past 10 years, this metric has ranged from a low of 62.62 to a high of 145.18. Based on the distribution chart, Chemical Works of Gedeon Richter ranks #249 out of 923 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Chemical Works of Gedeon Richter has a GF Score™ of 94/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Chemical Works of Gedeon Richter's Days Payable compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Chemical Works of Gedeon Richter ranks #249 out of 923 companies for Days Payable. This puts Chemical Works of Gedeon Richter in the upper half of its industry. The industry median Days Payable is 90.98. Historically, Chemical Works of Gedeon Richter's own Days Payable has ranged from 62.62 to 145.18 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.98, based on 923 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Chemical Works of Gedeon Richter and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Chemical Works of Gedeon Richter's current Days Payable is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chemical Works of Gedeon Richter stock overvalued right now?
Based on GuruFocus' analysis, Chemical Works of Gedeon Richter (RGEDF) is currently considered Modestly Overvalued. The stock's GF Value™ is $35.22, compared to a current price of $39.59 — trading 12.4% above its estimated fair value. The current Days Payable is 0.00. Chemical Works of Gedeon Richter's overall GF Score™ is 94/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Chemical Works of Gedeon Richter (RGEDF), the current Days Payable is 0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Chemical Works of Gedeon Richter (RGEDF) Overvalued in 2026?

Based on GuruFocus' analysis, Chemical Works of Gedeon Richter stock appears to be overvalued. The current stock price of $39.59 is trading 12.4% above its estimated GF Value™ of $35.22. GuruFocus considers Chemical Works of Gedeon Richter to be Modestly Overvalued.

Key valuation signals for RGEDF:

  • Days Payable: 0.00
  • GF Value™: $35.22 vs. price of $39.59 (12.4% above fair value)
  • GF Score™: 94/100 with 3 warning signs

No single metric tells the full story. See the RGEDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Chemical Works of Gedeon Richter Business Description

Address Gyomroi ut 19-21, Budapest, HUN, 1103
Chemical Works of Gedeon Richter PLC is a pharmaceutical company. The company focuses on the development and manufacture of gynaecological, cardiovascular, and central nervous system products. It manufactures medicines including original, generic and licensed products for treatment in the therapeutic area. The group is active in two business segments namely, the Pharma segment comprising Women's Healthcare, Neuropsychiatry, Biotechnology, General Medicine, and Other pharma; and the Others segment includes the remaining wholesale and retail business of the Group and all other activities. The company operates internationally.
94GF Score

Get the complete analysis for RGEDF

Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$39.59
Price
$35.22
GF Value